Sinonasal malignancies make up< 5% of all head and neck neoplasms, with an incidence of
0.5–1.0 per 100,000. The outcome of these rare malignancies has been poor, whereas …

Our objective was to review recent developments in diagnosis, staging, and treatment of
esthesioneuroblastoma (ENB). A meta-analysis of publications between 1990 and 2000 was …

Pathology and Genetics of Head and Neck Tumoursis the latest volume in the new WHO
series, on histological and genetic typing of human tumours. This authoritative, concise …

BACKGROUND The authors reviewed treatment results in patients with nasal and paranasal
sinus carcinoma from a large retrospective cohort and conducted a systematic literature …

Abstract FORTY-NINE PATIENTS WITH esthesioneuroblastoma were treated at the Mayo
Clinic between 1951 and 1990. Their clinical manifestations and treatment results were …

Few neoplasms are unique to the sinonasal tract, but sinonasal undifferentiated carcinoma
and olfactory neuroblastoma are malignant tumors which require unique management. Due …

Objectives To investigate the characteristics associated with survival in
esthesioneuroblastoma and to determine whether the modified Kadish staging system can …

Importance Current olfactory neuroblastoma (ONB) staging systems inadequately delineate
locally advanced tumors, do not incorporate tumor grade, and poorly estimate survival and …

Introduction Many controversies exist in the diagnosis and management of this aggressively
malignant condition, mainly because of limited literature and lack of randomized control …

Background. Olfactory neuroblastoma (ONB) is a rare tumor arising from the olfactory
neuroepithelium. There is no universally accepted staging system, and treatment …